<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药云端工作室 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-10T20:25:20+08:00</updated>
  <subtitle>医药行业领先的智库，连接政策与市场的桥梁</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>751个医保审查品种被砍掉一半？基药目录调整又有新消息......</title>
    <updated>2020-11-10T18:54:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/EJti87ZyCeydhzD3S5ziQA</id>
    <link href="https://mp.weixin.qq.com/s/EJti87ZyCeydhzD3S5ziQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>湖北药品带量采购来了！谈判议价、议价采购……</title>
    <updated>2020-11-10T18:54:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/kRVWyRSYqPXZSQ-oC7TT2Q</id>
    <link href="https://mp.weixin.qq.com/s/kRVWyRSYqPXZSQ-oC7TT2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>冠脉支架国采结果落定，湖南耗材集采正式开启</title>
    <updated>2020-11-10T18:54:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/YaNNPk4Zzg4aNxQ5Jtn_1A</id>
    <link href="https://mp.weixin.qq.com/s/YaNNPk4Zzg4aNxQ5Jtn_1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《中国药品采购政策研究报告2020》11.16广州发布</title>
    <updated>2020-11-10T18:54:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/b_DSP0msbY-wfzpJcki9ZQ</id>
    <link href="https://mp.weixin.qq.com/s/b_DSP0msbY-wfzpJcki9ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药不能只盯医保，对仿制药也别相煎太急</title>
    <updated>2020-11-09T19:15:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/tvh34KHRTLDRACXVDWIl9w</id>
    <link href="https://mp.weixin.qq.com/s/tvh34KHRTLDRACXVDWIl9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>进博会现场签约：药品、耗材带量采购成果，上海采购将超8亿​</title>
    <updated>2020-11-09T19:15:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/is_QRseFX-PsbjmslEN8GA</id>
    <link href="https://mp.weixin.qq.com/s/is_QRseFX-PsbjmslEN8GA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>苏南、苏北6市联手，211家医院耗材带量采购</title>
    <updated>2020-11-09T19:15:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/P8ob_CbAwis0HfM7mLslmQ</id>
    <link href="https://mp.weixin.qq.com/s/P8ob_CbAwis0HfM7mLslmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>研报发布：《中国药品采购政策研究报告2020》</title>
    <updated>2020-11-09T19:15:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/_h55_TEUTqomYxpNBL85dw</id>
    <link href="https://mp.weixin.qq.com/s/_h55_TEUTqomYxpNBL85dw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百亿PPI市场，集采后会怎样？</title>
    <updated>2020-11-08T19:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/W4JMF8Is_421_IwRi9A1qA</id>
    <link href="https://mp.weixin.qq.com/s/W4JMF8Is_421_IwRi9A1qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10产品拟中选冠脉支架国采；四川将开展合理用药评估；浙江启动小单元竞价｜云端周报</title>
    <updated>2020-11-08T19:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/rfrOp4dXGuqRfY8KjBdQrQ</id>
    <link href="https://mp.weixin.qq.com/s/rfrOp4dXGuqRfY8KjBdQrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【一致性评价最新通报】本周5款药品全国首家过评，涉三款注射剂</title>
    <updated>2020-11-08T19:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/G-CWjYkP7Fz37bgZ301oBA</id>
    <link href="https://mp.weixin.qq.com/s/G-CWjYkP7Fz37bgZ301oBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>广州11.16：走向医药市准入的专业化之路 暨《中国药品采购政策研究报告2020》发布会</title>
    <updated>2020-11-08T19:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/orip62oXpyEjqhJ5IVQwmQ</id>
    <link href="https://mp.weixin.qq.com/s/orip62oXpyEjqhJ5IVQwmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>双循环经济下本土医药企业的出路</title>
    <updated>2020-11-07T18:40:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/XdZRXAtxRyb1xUyn3X3Cfw</id>
    <link href="https://mp.weixin.qq.com/s/XdZRXAtxRyb1xUyn3X3Cfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>带量采购时代的医药政策和市场环境</title>
    <updated>2020-11-07T18:40:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/7uKlqSX9-3KAHTMtQIOj1g</id>
    <link href="https://mp.weixin.qq.com/s/7uKlqSX9-3KAHTMtQIOj1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品招采新玩法，浙江启动小单元竞价</title>
    <updated>2020-11-06T19:03:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/5zKGT7wdg5UJg6m17O43ZQ</id>
    <link href="https://mp.weixin.qq.com/s/5zKGT7wdg5UJg6m17O43ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>省采出来了！安徽最高降幅76.55%，江西10家企业拟中选</title>
    <updated>2020-11-06T19:03:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/XESyAvyyDCAUS9CIgDL_WA</id>
    <link href="https://mp.weixin.qq.com/s/XESyAvyyDCAUS9CIgDL_WA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DIP试点名单来了，71个城市纳入（附名单）</title>
    <updated>2020-11-06T19:03:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/2LivNiEU4U7zQHwHDXCMuw</id>
    <link href="https://mp.weixin.qq.com/s/2LivNiEU4U7zQHwHDXCMuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11.16广州，风轻老师将与您分享《市场准入方式的新思考》</title>
    <updated>2020-11-06T19:03:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/12kAI4vLffuM10kKu5lueQ</id>
    <link href="https://mp.weixin.qq.com/s/12kAI4vLffuM10kKu5lueQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>冠脉支架国采结果出炉，10产品拟中选，国家医保局做出回应（视频+文字）</title>
    <updated>2020-11-05T16:51:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/ekEqgJSIxlOCzRRRr5QgNw</id>
    <link href="https://mp.weixin.qq.com/s/ekEqgJSIxlOCzRRRr5QgNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>省级集采，一线强省：浙江8个，河南31个， 江苏与原研药价差大的品种……</title>
    <updated>2020-11-05T16:51:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/Gzvy1O9p_carljwSq4YExg</id>
    <link href="https://mp.weixin.qq.com/s/Gzvy1O9p_carljwSq4YExg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>